The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 16, 2014
Filed:
Jun. 29, 2011
Applicants:
Guy Bouvier, Biot, FR;
Matthew James Leoni, Hampton, NJ (US);
Michael Graeber, Lawrenceville, NJ (US);
Inventors:
Guy Bouvier, Biot, FR;
Matthew James Leoni, Hampton, NJ (US);
Michael Graeber, Lawrenceville, NJ (US);
Assignee:
Galderma Research & Development, Biot, FR;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/502 (2006.01); A61K 8/49 (2006.01); A61K 9/00 (2006.01); A61K 9/12 (2006.01); A61K 31/137 (2006.01); A61K 31/4174 (2006.01); A61K 47/06 (2006.01); A61K 47/10 (2006.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01); A61Q 17/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/502 (2013.01); A61K 8/4946 (2013.01); A61K 9/0014 (2013.01); A61K 9/12 (2013.01); A61K 31/137 (2013.01); A61K 31/4174 (2013.01); A61K 47/06 (2013.01); A61K 47/10 (2013.01); A61K 47/32 (2013.01); A61K 47/38 (2013.01); A61Q 17/04 (2013.01); A61K 2800/78 (2013.01);
Abstract
Methods, compositions and products for preventing skin tumor formation or inhibiting development of an existing skin tumor in a subject are described. The methods involve administering to the subject a composition containing an α2 adrenergic receptor agonist, such brimonidine.